BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 2003
View Archived Issues
Guangdong Medicine Group signs agreement for Alferon N and Ampligen
Read More
Ciprofloxacin GR as effective as Cipro for UTIs
Read More
Multiferon gives positive in vitro results against SARS
Read More
Good safety and pharmacokinetic profile for oral insulin in type 1 diabetes
Read More
High compliance rate, no effects on lung function reported for inhaled insulin in type 2 diabetes
Read More
Analgesic efficacy described for LAS-34475 in a model of acute dental pain
Read More
Increased insulin sensitivity and glycemic control associated with chromium in type 2 diabetes
Read More
GSK scientists identify novel surfactants for inhalable aerosols
Read More
Novel GnRH modulators prepared and tested by Pfizer researchers
Read More
Biphenyl-based antiandrogenic agents covered by Endorecherche patent
Read More
Fujisawa claims novel adenosine deaminase inhibitors and their use
Read More
Spanish researchers patent an optically active antifungal agent
Read More
Antifungal lipopeptides in early development at Fujisawa
Read More
Osiris grants mesenchymal stem cell technology rights to JCR
Read More
Valera adopted as new name for Hydro Med Sciences
Read More
Continuation of phase I VRX-496 trial recommended
Read More
Fibromyalgia advisory meeting for Xyrem proof-of-principle trial
Read More
Genzyme seeks Japanese approval of Synvisc
Read More
Iseganan designated a fast track drug for VAP
Read More
Lumiracoxib safe and effective for moderate to severe postsurgical pain
Read More
Low incidence of hypoglycemia reported with insulin glargine in diabetics
Read More
Pramlintide induces weight loss and slows gastric emptying in insulin-treated diabetics
Read More
Metabolic disease treatments to be developed under Amgen/Biovitrum collaboration
Read More
Small molecule selectively targeting HER2 selected for development by Pfizer
Read More
Dual inhibitors of HER1/HER2 presented at ACS meeting by Bristol-Myers Squibb
Read More
SAR leading to potent, selective and orally active JNK inhibitor AS-601245
Read More